Lombard Odier Asset Management (Europe) LTD Bristol Myers Squibb CO Transaction History

Lombard Odier Asset Management (Europe) LTD

$1.57 Billion
Q3 2024

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $502,709 - $547,450	-8,120 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $1.3 Million - $1.46 Million	-21,905 Reduced 72.96%	8,120 $513,000
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $350,655 - $397,356	6,073 Added 25.35%	30,025 $1.86 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $168,786 - $187,037	2,939 Added 13.99%	23,952 $1.44 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $155,347 - $225,755	-3,348 Reduced 13.74%	21,013 $1.17 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $342,255 - $446,441	6,955 Added 39.96%	24,361 $1.56 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $27,352 - $30,245	613 Added 3.65%	17,406 $789,000
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $31,127 - $35,109	564 Added 3.48%	16,793 $1.04 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $119,959 - $138,097	-2,002 Reduced 10.98%	16,229 $1.03 Million
Q4 2017 Feb 13, 2018	SELL	$59.94 - $65.35 $124,075 - $135,274	-2,070 Reduced 10.2%	18,231 $1.12 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $1.12 Million - $1.29 Million	20,301	20,301 $1.29 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$10.9 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.2 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.39 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.52 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.54 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Europe) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Europe) LTD with notifications on news.

Account